U.S. Markets closed

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.23-0.12 (-0.69%)
At close: 4:00PM EDT

17.23 0.00 (0.00%)
After hours: 4:06PM EDT

People also watch
  • MUTE Marchalk MUTE Peter for a better board - Trash talking idiots
  • The shorts are in total control. http://regsho.finra.org/FNSQshvol20170724.txt

  • Wikipedia updated their Laron syndrome page today with a mention Insmed. Do your own DD, and the truth is staring you in the face.
  • Impulse control is key. https://www.youtube.com/watch?v=OPUvXeXXjKM

    The Sopranos - Tony teaches Christopher about impulse control
    Check out TheSopranoCrazy t-shirts at: http://skreened.com/thesopranocrazy/
  • Anyone notice the pre-market activity? 1(one) share traded so far. Who buys or sells just one share? Marchalk is right again.
  • PUMP, PUMP, PUMP and then the obvious... A simple google search for the last 24 hours reveals the truth behind the hype. Yes, it is sad, but it is also true. This is how the scheme works. Amateurs buy high while the pros dump.
  • \What left on the investorvillage board?\ Besides a couple of those who show they have no idea of what is transpiring with markets\ There goes another 50k Trade!!! \seemingly spending their lives on 1 stock\so sad\
    Cubbie posts Glass door bulletin board stuff\ There is new jobs! \ So why do those jobs seem to always hang around? \
    BECAUSE THEY ARE CONTINGENT ON THE PHASE3 TRIAL RESULTS\ Hiring of sales people{strongly doubt it}will take a lot of time and cash into 2019\Besides that ZERO of value and those posting MISINFORMATION\LOOKS LIKE INVVILLAGE IN financial trouble with SALE! on membership and dwindling #s\INSM board has 5 real members 3 of whom use multiple identities\ EOS
  • If one does not know a dang thing about trading \one should not say stupid things about money managers or the trading currently and obviously underway with INSM\JAD9000 call this "World class manipulation"\which shows clear ignorance\"We seem to have an MM exercising world class manipulation and pinning of the share price." and shows heshe hasnt any idea about the pending results timeline| " Hopefully they can get the data to the marketplace in the next 30 days or so. IMPOSSIBLE |
    and if all that wasnt stupid enough! "It would absolutely crush the remaining shorts and boost the offering price. " THIS PERSON MUST BE POSTING TO THEMSELVES BECAUSE ANYONE ELSE IS LAUGHING!\
  • Attention : Announced this morning =\the last patient has exited the trial \
  • More and more a dilution feels like its coming although I would prefer a partner or buyout
  • Thanks kinkey
    Needs to be reported we are at least 2 months from results with last patient exiting
    after today and listening I am much more cautious
  • from another poster on another venue I asked about this poster planting "seeds of doubt" he responded that as of now he sees no reason to base his investment on a notoriously inaccurate government site. Insmed will release results aprx 4-6 weeks after the trial is unblinded to glean data and he guesstimates Oct although as early as next month is possible.He continues to profit with swing trades with INSM
  • INSM was almost $29 two years ago.........now about $17........a total disaster!!!! That's a fact morons!
  • Thanks Peter. Needs to be reported that scammers are posting phony claims. Always rely on verifiable facts.
  • \Yesterdays call gave substantive info to develop a timeline on the drugs progress\ dilution and partner possibilities \
    \Inv board shows posters have no knowledge or experience to comment a few below \
  • Newbie Alert!!!!!.....Marchalk is right. He has provided irrefutable evidence in his posts. Just read the facts and examine the proof for yourself. Don't let these boiler room losers steal your money.
  • "Media headlines about Insmed (NASDAQ:INSM) have trended somewhat positive recently, according to Accern Sentiment Analysis". They must have missed the balance sheet remarks.
  • Insmed ended the first quarter of 2017 with approximately $55 million in debt.
  • Ameriprise Financial Inc. cut its stake in shares of Insmed, Inc. (NASDAQ:INSM) by 10.4% during the first quarter, according to its most recent Form 13F filing with ...